Zoledronic Acid Market, By Indication (Osteoporosis Treatment & Prevention (Postmenopausal Osteoporosis, Male Osteoporosis, Glucocorticoid-Induced Osteoporosis), Oncology-Related Indication (Bone Metastases), and Others (Paget’s Disease of Bone, Pediatric Osteogenesis Imperfecta [off-label use], etc.)), By Route of Administration (Intravenous infusion and Oral administration), By Dosage Strength (4 mg/100 mL single-use ready-to-use bottle, 4 mg/5 mL single-use vial, and 5 mg in a 100 mL ready to infuse solution), By Age Group (Geriatric and Adult), By Gender (Female and Male), By Product Type (Branded Zoledronic Acid and Generic Zoledronic Acid), By End User (Hospitals & Specialty Clinics, Cancer Treatment Centers, Ambulatory Surgical Centers (ASCs), Long-term care facilities, and Others (Research Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)